Accession Number : ADA305956

Title :   Studies Into Militarily Relevant Infectious Diseases of Interest to Both United States and Royal Thai Governments.

Descriptive Note : Annual rept. 15 Oct 94-14 Oct 95,

Corporate Author : ARMED FORCES RESEARCH INST OF MEDICAL SCIENCES APO SAN FRANCISCO 96346

Personal Author(s) : Singharaj, Pricha

PDF Url : ADA305956

Report Date : 14 NOV 1995

Pagination or Media Count : 43

Abstract : Cooperative Agreement #DAMD17-95-2-5001 was implemented 15 October 1994 to provide funding support for Royal Thai Army investigators at the Armed Forces Research Institute of Medical Sciences (AFRIMS) engaged in research activities in collaboration with US Army investigators. The principal focus of research under the agreement is directed to activities to prepare for development and testing of vaccine(s) for the prevention of HIV infection and/or disease. During the reporting period, research activities were directed in 3 primary areas (1) study of the natural history of HIV infection/disease in Thais to define and establish endpoints for projected vaccine efficacy testing; (2) cohort development studies to define an appropriate population(s) for vaccine testing; and (3) implementation of phase I/II vaccine studies to determine safety and immunogenicity of potential vaccines in Thais. Other efforts under the cooperative agreement during the reporting period included (1) animal care and handling, including multiple small animal species and a primate colony, in support of other ongoing research activities at AFRIMS, exclusive of HIV research; and (2) site maintenance activities in support of research activities including glassware and utilities support.

Descriptors :   *MILITARY MEDICINE, *MILITARY RESEARCH, *INFECTIOUS DISEASES, *HUMAN IMMUNODEFICIENCY VIRUSES, *VACCINES, TEST AND EVALUATION, MAINTENANCE, UNITED STATES, SITES, DISEASES, GLASS, MEDICINE, ANIMALS, AGREEMENTS, COOPERATION, NATURAL HISTORY, IMMUNOGENS, ANIMAL HUSBANDRY.

Subject Categories : Medicine and Medical Research
      Microbiology

Distribution Statement : APPROVED FOR PUBLIC RELEASE